AAAAAA
Results:
1-21
|
Results: 21
Authors:
van Muijlwijk-Koezen, JE
Timmerman, H
van der Sluis, RP
van de Stolpe, AC
Menge, WMPB
Beukers, MW
van der Graaf, PH
de Groote, M
IJzerman, AP
Citation: Je. Van Muijlwijk-koezen et al., Synthesis and use of FSCPX, an irreversible adenosine A(1) antagonist, as a 'receptor knock-down' tool, BIOORG MED, 11(6), 2001, pp. 815-818
Authors:
Van Acker, FAA
Hulshof, JW
Haenen, GRMM
Menge, WMPB
van der Vijgh, WJF
Bast, A
Citation: Faa. Van Acker et al., New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicity, FREE RAD B, 31(1), 2001, pp. 31-37
Authors:
Alves-Rodrigues, A
Lemstra, S
Vollinga, RC
Menge, WMPB
Timmerman, H
Leurs, R
Citation: A. Alves-rodrigues et al., Pharmacological analysis of immepip and imetit homologues. Further evidence for histamine H-3 receptor heterogeneity?, BEH BRA RES, 124(2), 2001, pp. 121-127
Authors:
Hough, LB
Nalwalk, JW
Leurs, R
Menge, WMPB
Timmerman, H
Citation: Lb. Hough et al., Significance of GABAergic systems in the action of improgan, a non-opioid analgesic, LIFE SCI, 68(24), 2001, pp. 2751-2757
Authors:
De Esch, IJP
Mills, JEJ
Perkins, TDJ
Romeo, G
Hoffmann, M
Wieland, K
Leurs, R
Menge, WMPB
Nederkoorn, PHJ
Dean, PM
Timmerman, H
Citation: Ijp. De Esch et al., Development of a pharmacophore model for histamine H-3 receptor antagonists, using the newly developed molecular modeling program SLATE, J MED CHEM, 44(11), 2001, pp. 1666-1674
Authors:
Gelens, E
Koot, WJ
Menge, WMPB
Ottenheijm, HCJ
Timmerman, H
Citation: E. Gelens et al., Solid-phase synthesis of 4-substituted imidazoles using a scaffold approach, BIOORG MED, 10(17), 2000, pp. 1935-1938
Authors:
de Esch, IJP
Timmerman, H
Menge, WMPB
Nederkoorn, PHJ
Citation: Ijp. De Esch et al., A qualitative model for the histamine H-3 receptor explaining agonistic and antagonistic activity simultaneously, ARCH PHARM, 333(8), 2000, pp. 254-260
Authors:
Hough, LB
Nalwalk, JW
Leurs, R
Menge, WMPB
Timmerman, H
Citation: Lb. Hough et al., Antinociceptive activity of derivatives of improgran and burimamide, PHARM BIO B, 65(1), 2000, pp. 61-66
Authors:
Windhorst, AD
Timmerman, H
Worthington, EA
Bijloo, GJ
Nederkoorn, PHJ
Menge, WMPB
Leurs, R
Herscheid, JDM
Citation: Ad. Windhorst et al., Characterization of the binding site of the histamine H-3 receptor. 2. Synthesis, in vitro pharmacology, and QSAR of a series of monosubstituted benzyl analogues of thioperamide, J MED CHEM, 43(9), 2000, pp. 1754-1761
Authors:
van Acker, FAA
Hageman, JA
Haenen, GRMM
van der Vijgh, WJF
Bast, A
Menge, WMPB
Citation: Faa. Van Acker et al., Synthesis of novel 3,7-substituted-2-(3 ',4 '-dihydroxyphenyl)flavones with improved antioxidant activity, J MED CHEM, 43(20), 2000, pp. 3752-3760
Authors:
van Muijlwijk-Koezen, JE
Timmerman, H
van der Goot, H
Menge, WMPB
Kunzel, JFV
de Groote, M
IJzerman, AP
Citation: Je. Van Muijlwijk-koezen et al., Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor, J MED CHEM, 43(11), 2000, pp. 2227-2238
Authors:
Hough, LB
Nalwalk, JW
Chen, Y
Schuller, A
Zhu, Y
Zhang, J
Menge, WMPB
Leurs, R
Timmerman, H
Pintar, JE
Citation: Lb. Hough et al., Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice, BRAIN RES, 880(1-2), 2000, pp. 102-108
Authors:
Windhorst, AD
Timmerman, H
Klok, RP
Custers, FGJ
Menge, WMPB
Leurs, R
Stark, H
Schunack, W
Gielen, EGJ
van Kroonenburgh, MJPG
Herscheid, JDM
Citation: Ad. Windhorst et al., Radiosynthesis and biodistribution of I-123-labeled antagonists of the histamine H-3 receptor as potential SPECT ligands, NUCL MED BI, 26(6), 1999, pp. 651-659
Authors:
Windhorst, AD
Timmerman, H
Klok, RP
Menge, WMPB
Leurs, R
Herscheid, JDM
Citation: Ad. Windhorst et al., Evaluation of [F-18]VUF 5000 as a potential PET ligand for brain imaging of the histamine H-3 receptor, BIO MED CH, 7(9), 1999, pp. 1761-1767
Authors:
De Esch, IJP
Gaffar, A
Menge, WMPB
Timmerman, H
Citation: Ijp. De Esch et al., Synthesis and histamine H-3 receptor activity of 4-(n-alkyl)-1H-imidazolesand 4-(omega-phenylalkyl)-1H-imidazoles, BIO MED CH, 7(12), 1999, pp. 3003-3009
Authors:
Windhorst, AD
Timmerman, H
Menge, WMPB
Leurs, R
Herscheid, JDM
Citation: Ad. Windhorst et al., Synthesis, in vitro pharmacology and radiosynthesis of N-(cis-4-fluoromethylcyclohexyl)-4-(1(H)-imidazol-4-yl)piperidine-1-thiocarbonamide (VUF 5000), a potential pet ligand for the histamine H-3 receptor., J LABEL C R, 42(3), 1999, pp. 293-307
Authors:
De Esch, IJP
Vollinga, RC
Goubitz, K
Schenk, H
Appelberg, U
Hacksell, U
Lemstra, S
Zuiderveld, OP
Hoffmann, M
Leurs, R
Menge, WMPB
Timmerman, H
Citation: Ijp. De Esch et al., Characterization of the binding site of the histamine H-3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)cyclopropylamine, J MED CHEM, 42(7), 1999, pp. 1115-1122
Authors:
Menge, WMPB
Timmerman, H
Citation: Wmpb. Menge et H. Timmerman, Substituted imidazoles, the key to histaminergic receptors, PHARMCHEM L, 30, 1998, pp. 145-158
Authors:
Windhorst, AD
Leurs, R
Menge, WMPB
Timmerman, H
Herscheid, JDM
Citation: Ad. Windhorst et al., Synthesis of radioligands for the histamine H-3 receptor, PHARMCHEM L, 30, 1998, pp. 159-174
Authors:
Hough, LB
Nalwalk, JW
Leurs, R
Menge, WMPB
Timmerman, H
Citation: Lb. Hough et al., Antinociceptive activity of impentamine, a histamine congener, after CNS administration, LIFE SCI, 64(5), 1998, pp. PL79-PL86
Authors:
Bannoura, MD
Nalwalk, JW
Tang, YM
Carlile, ME
Leurs, R
Menge, WMPB
Timmerman, H
Hough, LB
Citation: Md. Bannoura et al., Absence of antinociceptive tolerance to improgan, a cimetidine analog, in rats, BRAIN RES, 814(1-2), 1998, pp. 218-221
Risultati:
1-21
|